Embecta (EMBC) Cost of Revenue (2020 - 2026)
Embecta (EMBC) posted Cost of Revenue of $94.0 million for Q1 2026, down 5.53% sequentially from $99.5 million in Q4 2025, and down 0.95% YoY from $94.9 million in Q1 2025.
Embecta (EMBC) Cost of Revenue (2020 - 2026) Analysis & Trends
Embecta has reported Cost of Revenue for 7 years, with the latest figure at $94.0 million in Q1 2026.
- Quarterly Cost of Revenue fell 0.95% year-over-year to $94.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $397.4 million (up 0.76% YoY) and the FY2025 annual result came in at $403.6 million, up 4.05% from the prior year.
- Cost of Revenue declined to $94.0 million in Q1 2026 per EMBC's latest filing, from $99.5 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $112.3 million in Q3 2024 and troughed at $82.4 million in Q2 2024.
- A 5-year average of $95.6 million and a median of $96.6 million in 2023 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2024 and 2025: Cost of Revenue dropped 14.7% in 2024, then increased 19.42% in 2025.
- Over 5 years, Cost of Revenue stood at $86.9 million in 2022, then grew by 5.18% to $91.4 million in 2023, then gained by 14.66% to $104.8 million in 2024, then retreated by 5.06% to $99.5 million in 2025, then fell by 5.53% to $94.0 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $94.0 million, $99.5 million, and $105.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.67 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.13 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 602.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.47 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 807.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1.93 Bn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 118.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 118.40 Mn |
| Jun 30, 2026 | 118.40 Mn |
| Mar 31, 2026 | 94.00 Mn |
| Mar 31, 2026 | 94.00 Mn |
| Dec 31, 2025 | 99.50 Mn |
| Dec 31, 2025 | 99.50 Mn |
| Sep 30, 2025 | 105.50 Mn |
| Sep 30, 2025 | 105.50 Mn |
| Jun 30, 2025 | 98.40 Mn |
| Jun 30, 2025 | 98.40 Mn |
| Mar 31, 2025 | 94.90 Mn |
| Mar 31, 2025 | 94.90 Mn |
| Dec 31, 2024 | 104.80 Mn |
| Dec 31, 2024 | 104.80 Mn |
| Sep 30, 2024 | 112.30 Mn |
| Sep 30, 2024 | 112.30 Mn |
| Jun 30, 2024 | 82.40 Mn |
| Jun 30, 2024 | 82.40 Mn |
| Mar 31, 2024 | 101.80 Mn |
| Mar 31, 2024 | 101.80 Mn |